ANZE BIOTECH - AHMEDABAD

Leaf

In Clinical Conditions of LRTI Provide Great Performance

Levofloxacin 500 / 250 mg. Tablets

  • Broad-spectrum antibacterial agent
  • active againt a range of gram-positive, gram-negative atypicals and anaerobes
  • Provides clinical and bacteriological efficacy in a range of infections


Leaf Provides advantage of once daily administration

Among all fluoroquinolones , levofloxacin shows grearest activity against the Mycobaterium tuberculosis

  • Respiratory tract infections
  • Nosicomial Pneumonia
  • Community acquired pneumonia
  • acute exacerbations of chronic bronchitis
  • urinary tract infections
  • skin & skin structure infections

 

Leaf

Related Products

Share this page on Facebook Twitter Google Digg Reddit LinkedIn Pinterest StumbleUpon Email